Market Cap: $351.48M
RI
Relmada Therapeutics, Inc.
RLMD
NASDAQUSD
Market Cap: $351.48M
Relmada Therapeutics: Innovations in Pain Management Relmada Therapeutics is at the forefront of developing novel therapies for the treatment of chronic pain, a significant health issue affecting mill…
Rising Challenges in Mental Health Therapeutics Relmada Therapeutics, a company specializing in innovative treatments for mental health disorders, finds itself navigating a landscape steeped in volati…
Relmada Therapeutics Takes Strides in Bladder Cancer Treatment Development Relmada Therapeutics Inc. is currently making headlines in the biopharmaceutical industry following the promising interim res…
Helus Pharma: Pioneering Psilocybin Treatments for Mental Health Disorders Helus Pharma, a clinical-stage pharmaceutical company, marks a pivotal moment in its journey towards developing innovative tr…
Helus Pharma's Trailblazing Journey in Psychedelic Psychiatry Helus Pharma, a clinical-stage pharmaceutical company formerly known as Cybin, advances the realm of mental health treatment with its prom…
Relmada Therapeutics Prepares for Significant Earnings Announcement Relmada Therapeutics, a biotechnology firm focused on developing innovative treatments for central nervous system disorders, is gear…
Relmada Therapeutics Prepares for Key Earnings Announcement Relmada Therapeutics (NASDAQ: RLMD) is on the verge of a significant earnings announcement scheduled for November 13, 2025. As the date appr…
Relmada Therapeutics: A Pivotal Earnings Announcement Approaches Relmada Therapeutics, a company focused on developing therapies for central nervous system disorders, is poised to release its quarterl…
Relmada Therapeutics Advances in Pain Management Research Relmada Therapeutics is making significant strides in the development of new treatments for chronic pain. The company focuses on the innovativ…
Relmada Therapeutics Expands Clinical Development for Chronic Pain Treatment Relmada Therapeutics is advancing its clinical development initiatives with a focus on chronic pain management. The company…
Relmada Therapeutics Pioneers New Pathways in Pain Management Relmada Therapeutics is at the forefront of developing innovative therapies for chronic pain management. The company focuses on advancing…
Relmada Therapeutics Advances in Pain Management Research Relmada Therapeutics, a clinical-stage biotechnology company focused on developing novel therapies for the treatment of chronic pain, makes si…